<p>Alpha Teknova（纳斯达克代码：TKNO - 获取免费报告）在周三发布的研究报告中被 Zacks Research 的股票分析师上调至 “持有” 评级，Zacks.com 报道。</p>
<p>获取 <strong>Alpha Teknova</strong> 警报：</p>
<p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Alpha Teknova 股票的 “卖出（d-）” 评级。一位研究分析师给予该股票强烈买入评级，一位给予买入评级，一位给予持有评级，还有一位给予卖出评级。根据 MarketBeat 的数据，Alpha Teknova 目前的平均评级为 “适度买入”，共识目标价为 10.00 美元。</p>
<p><strong>阅读我们最新的 TKNO 股票分析</strong></p>
<h2>Alpha Teknova 股票上涨 1.7%</h2>
<p>周三 TKNO 股票开盘价为 4.89 美元。Alpha Teknova 的年低为 3.94 美元，年高为 10.37 美元。该公司的市值为 2.6176 亿美元，市盈率为-13.97，贝塔值为 0.40。该公司的 50 日移动平均价格为 4.95 美元，200 日移动平均价格为 4.97 美元。公司的债务与股本比率为 0.18，速动比率为 4.27，流动比率为 5.27。</p>
<p>Alpha Teknova（纳斯达克代码：TKNO - 获取免费报告）最后一次发布财报是在 11 月 6 日，报告显示该季度每股收益（EPS）为（0.08 美元），超出市场共识预期的（0.09 美元）0.01 美元。Alpha Teknova 的股本回报率为-23.53%，净利润率为-45.78%。该公司在该季度的收入为 1045 万美元，而分析师预期为 1023 万美元。平均而言，股票研究分析师预计 Alpha Teknova 在当前年度将发布-0.58 的每股收益。</p>
<h2>机构投资者对 Alpha Teknova 的看法</h2>
<p>几家大型投资者最近增加或减少了对该公司的投资。Walleye Capital LLC 在第一季度购买了 Alpha Teknova 的新股份，价值约为 88,000 美元。OMERS ADMINISTRATION Corp 在第一季度将其在 Alpha Teknova 的股份提高了 101.2%。OMERS ADMINISTRATION Corp 现在拥有 80,700 股该公司的股票，价值 419,000 美元，此前在上个季度又购买了 40,600 股。Alpine Global Management LLC 在第一季度购买了 Alpha Teknova 的新股份，价值 128,000 美元。高盛集团在第一季度将其在 Alpha Teknova 的股份提高了 68.3%。高盛集团现在拥有 90,595 股该公司的股票，价值 470,000 美元，此前在此期间又购买了 36,763 股。最后，McAdam LLC 在第一季度收购了 Alpha Teknova 的新股份，价值约为 60,000 美元。对冲基金和其他机构投资者持有该股票的 13.81%。</p>
<h2>Alpha Teknova 公司简介</h2>
<p>（获取免费报告）</p>
<p>Alpha Teknova, Inc 在美国和国际上生产用于研究、发现、开发和商业化新疗法、疫苗和分子诊断的关键试剂。该公司提供用于细胞生长和克隆的预制培养基板；用于细胞扩增的液体细胞培养基和补充剂；以及用于样本操作、重悬和纯化的分子生物学试剂。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 Alpha Teknova</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>2026 年应避免的三只最近被下调评级的股票</li>
<li>如何从价值投资中获利</li>
<li>芯片热潮回归：三只有巨大收益潜力的股票</li>
<li>除了喝咖啡，还有三种投资咖啡的方法</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年反弹</li>
</ul>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Alpha Teknova 吗？</h2>
<p>在考虑 Alpha Teknova 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Alpha Teknova 并不在名单上。</p>
<p>虽然 Alpha Teknova 目前在分析师中有适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TKNO

<p>Zacks Research 将 Alpha Teknova 的评级上调至 “持有”，而 Weiss Ratings 重申了 “卖出” 评级。该股票的平均评级为适度买入，目标价格共识为 10.00 美元。TKNO 股票上涨 1.7%，至 4.89 美元。Alpha Teknova 报告的收益好于预期，净利润率为负 45.78%。机构投资者已调整了在该公司的持股。Alpha Teknova 生产用于新疗法和诊断的试剂</p>

<p>Alpha Teknova (NASDAQ:TKNO - Get Free Report) was upgraded by stock analysts at Zacks Research to a &#34;hold&#34; rating in a research report issued on Wednesday,Zacks.com reports.</p>
<div class="lb-trans"><p>Alpha Teknova（纳斯达克代码：TKNO - 获取免费报告）在周三发布的研究报告中被 Zacks Research 的股票分析师上调至 “持有” 评级，Zacks.com 报道。</p>
</div><p>Get <strong>Alpha Teknova</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Alpha Teknova</strong> 警报：</p>
</div><p>Separately, Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of Alpha Teknova in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Alpha Teknova presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $10.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Alpha Teknova 股票的 “卖出（d-）” 评级。一位研究分析师给予该股票强烈买入评级，一位给予买入评级，一位给予持有评级，还有一位给予卖出评级。根据 MarketBeat 的数据，Alpha Teknova 目前的平均评级为 “适度买入”，共识目标价为 10.00 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on TKNO</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 TKNO 股票分析</strong></p>
</div><h2>Alpha Teknova Stock Up 1.7%</h2>
<div class="lb-trans"><h2>Alpha Teknova 股票上涨 1.7%</h2>
</div><p>TKNO stock opened at $4.89 on Wednesday. Alpha Teknova has a one year low of $3.94 and a one year high of $10.37. The firm has a market cap of $261.76 million, a PE ratio of -13.97 and a beta of 0.40. The firm's 50 day moving average price is $4.95 and its 200-day moving average price is $4.97. The company has a debt-to-equity ratio of 0.18, a quick ratio of 4.27 and a current ratio of 5.27.</p>
<div class="lb-trans"><p>周三 TKNO 股票开盘价为 4.89 美元。Alpha Teknova 的年低为 3.94 美元，年高为 10.37 美元。该公司的市值为 2.6176 亿美元，市盈率为-13.97，贝塔值为 0.40。该公司的 50 日移动平均价格为 4.95 美元，200 日移动平均价格为 4.97 美元。公司的债务与股本比率为 0.18，速动比率为 4.27，流动比率为 5.27。</p>
</div><p>Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.01. Alpha Teknova had a negative return on equity of 23.53% and a negative net margin of 45.78%.The company had revenue of $10.45 million during the quarter, compared to analysts' expectations of $10.23 million. On average, equities research analysts anticipate that Alpha Teknova will post -0.58 EPS for the current year.</p>
<div class="lb-trans"><p>Alpha Teknova（纳斯达克代码：TKNO - 获取免费报告）最后一次发布财报是在 11 月 6 日，报告显示该季度每股收益（EPS）为（0.08 美元），超出市场共识预期的（0.09 美元）0.01 美元。Alpha Teknova 的股本回报率为-23.53%，净利润率为-45.78%。该公司在该季度的收入为 1045 万美元，而分析师预期为 1023 万美元。平均而言，股票研究分析师预计 Alpha Teknova 在当前年度将发布-0.58 的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Alpha Teknova</h2>
<div class="lb-trans"><h2>机构投资者对 Alpha Teknova 的看法</h2>
</div><p>Several large investors have recently added to or reduced their stakes in the business. Walleye Capital LLC purchased a new position in shares of Alpha Teknova in the 1st quarter valued at about $88,000. OMERS ADMINISTRATION Corp lifted its stake in Alpha Teknova by 101.2% in the first quarter. OMERS ADMINISTRATION Corp now owns 80,700 shares of the company's stock valued at $419,000 after buying an additional 40,600 shares during the last quarter. Alpine Global Management LLC purchased a new stake in Alpha Teknova in the 1st quarter valued at $128,000. Goldman Sachs Group Inc. boosted its stake in shares of Alpha Teknova by 68.3% during the first quarter. Goldman Sachs Group Inc. now owns 90,595 shares of the company's stock worth $470,000 after buying an additional 36,763 shares during the period. Finally, McAdam LLC acquired a new stake in Alpha Teknova during the 1st quarter worth approximately $60,000. 13.81% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家大型投资者最近增加或减少了对该公司的投资。Walleye Capital LLC 在第一季度购买了 Alpha Teknova 的新股份，价值约为 88,000 美元。OMERS ADMINISTRATION Corp 在第一季度将其在 Alpha Teknova 的股份提高了 101.2%。OMERS ADMINISTRATION Corp 现在拥有 80,700 股该公司的股票，价值 419,000 美元，此前在上个季度又购买了 40,600 股。Alpine Global Management LLC 在第一季度购买了 Alpha Teknova 的新股份，价值 128,000 美元。高盛集团在第一季度将其在 Alpha Teknova 的股份提高了 68.3%。高盛集团现在拥有 90,595 股该公司的股票，价值 470,000 美元，此前在此期间又购买了 36,763 股。最后，McAdam LLC 在第一季度收购了 Alpha Teknova 的新股份，价值约为 60,000 美元。对冲基金和其他机构投资者持有该股票的 13.81%。</p>
</div><h2>Alpha Teknova Company Profile</h2>
<div class="lb-trans"><h2>Alpha Teknova 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.</p>
<div class="lb-trans"><p>Alpha Teknova, Inc 在美国和国际上生产用于研究、发现、开发和商业化新疗法、疫苗和分子诊断的关键试剂。该公司提供用于细胞生长和克隆的预制培养基板；用于细胞扩增的液体细胞培养基和补充剂；以及用于样本操作、重悬和纯化的分子生物学试剂。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Alpha Teknova</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>How to Profit From Value Investing</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
<li>3 Ways To Invest In Coffee, Other Than Drinking It</li>
<li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Alpha Teknova</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>2026 年应避免的三只最近被下调评级的股票</li>
<li>如何从价值投资中获利</li>
<li>芯片热潮回归：三只有巨大收益潜力的股票</li>
<li>除了喝咖啡，还有三种投资咖啡的方法</li>
<li>甲骨文股票遭重创：为何其 AI 管道可能推动 2026 年反弹</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alpha Teknova Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Alpha Teknova 吗？</h2>
</div><p>Before you consider Alpha Teknova, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Alpha Teknova 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Alpha Teknova 并不在名单上。</p>
</div><p>While Alpha Teknova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alpha Teknova 目前在分析师中有适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Alpha Teknova（纳斯达克股票代码：TKNO）在 Zacks Research 被上调评级